Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
61,447,968
-
Share change
-
+2,201,489
-
Total reported value
-
$3,637,020,281
-
Put/Call ratio
-
31%
-
Price per share
-
$59.19
-
Number of holders
-
317
-
Value change
-
-$76,699,636
-
Number of buys
-
178
-
Number of sells
-
180
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2022
As of 30 Jun 2022,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
317 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,447,968 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, Champlain Investment Partners, LLC, Invesco Ltd., STATE STREET CORP, BROWN CAPITAL MANAGEMENT LLC, ALLIANCEBERNSTEIN L.P., and Bellevue Group AG.
This page lists
317
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.